Vivos Therapeutics, INC S-1 registration statements

Vivos Therapeutics has filed an amendment to its S-1 registration statement, primarily to remove reliance on previously incorporated information, relating to the potential resale of common stock and warrants.

Vivos Therapeutics is registering for resale 854,332 shares of common stock, including shares underlying warrants issued in recent private placements.

Vivos Therapeutics has filed an amendment to its Form S-1 registration statement to allow for the resale of up to 1,737,259 shares of common stock underlying warrants held by a selling stockholder.

Vivos Therapeutics has filed a registration statement for the resale of up to 1,737,259 shares of common stock by a selling stockholder, derived from warrants issued in private placements.